Introduction {#section1-1559325815592393}
============

Malaria is a leading cause of mortality and morbidity in developing areas of the world ([@bibr7-1559325815592393]). It is endemic in at least 87 countries, placing approximately 2.5 billion people at risk ([@bibr20-1559325815592393]; [@bibr18-1559325815592393]). The consequences of severe malaria include coma and death if untreated, young children and pregnant women being most vulnerable. The use of antimalarial drugs as prophylaxis has generated drug resistance, which is of great concern. The development of resistance to chloroquine phosphate and other agents further necessitated the development of new antimalarial compounds for use as monotherapy or in combination with existing methods of treatment. Artemisinin is currently the most widely used antimalarial drug against drug-resistant malaria. It is a Chinese herb that has been used over thousands of years for the treatment of fever. Artemisinin, also known as quinghaosu, is a sesquiterpene lactone extracted from the leaves of *Artemisia annua* (sweet wormwood).

Artesunate, a water-soluble semisynthetic hemisuccinate derivative of artemisinin, is a drug used to treat malaria, especially chloroquine-resistant malaria. It is synthesized by reacting dihydroartemisinin and succinic acid anhydride in an alkaline medium. Artesunate and its active metabolite dihydroartemisinin are potent blood schizonticides, highly effective against multidrug-resistant strains of *Plasmodium falciparum*. Hence, it is increasingly used widely for the treatment and management of malaria. A combination of mefloquine and artesunate is highly effective in multidrug-resistant malaria ([@bibr61-1559325815592393]). The effectiveness of artesunate is due to its rapid and complete hydrolysis to form dihydroartemisinin that is 3- to 5-folds more active than the parent compound ([@bibr34-1559325815592393]). Recent observations indicate that oxidative stress also plays a role in the activity of artemisinins against cancer cells ([@bibr11-1559325815592393]). Furthermore, artesunate is able to induce oxidative DNA damage in mammalian cells (Berdelle et al. 2011), and the DNA damage induced by artesunate also contributes to its therapeutic effect against cancer cells ([@bibr50-1559325815592393]). Further, artesunate is capable of ameliorating airway inflammation and oxidative lung damage via the suppression of pro-oxidant production and restoration of antioxidant expression and their activities in the lung ([@bibr21-1559325815592393]).

However, it has been stated that the use of these drugs should be controlled and restricted only to proven multidrug resistance or severe malaria in order to preserve their efficacy ([@bibr38-1559325815592393]). The possibility of administration of overdose and misappropriation in the usage of antimalarials is very common, as drugs though useful in the treatment of disease condition could also produce adverse side effects in the individual. These untoward effects may be harmful to the patient. Following increased resistance of malarial parasites to conventional drugs in the malarial regions of the world, the World Health Organization has been promoting artemisinin-based combination therapy for treating uncomplicated malaria ([@bibr44-1559325815592393]; [@bibr35-1559325815592393]). Recent studies show that coadministration of artesunate and amodiaquine altered lipid profile parameters and liver function markers but spared the kidney. The drugs also increased the risk of erythrocyte oxidative damage as evidenced by the elevated concentration of malonyldialdehyde (MDA), an oxidative stress marker. Hence, artesunate causes adverse effects when the drug is misused, and therefore it should be taken with prescription only when there is a clinical evidence of malarial parasite infection ([@bibr1-1559325815592393]).

Many antimalarial drugs have been associated with male reproductive dysfunction. Chloroquine has been reported to reduce sperm motility and hence fertility by a reduction in the average number of fetuses of cohabited female rats ([@bibr2-1559325815592393]). Artesunate has also been shown to cause a decrease in sperm motility in guinea pigs ([@bibr43-1559325815592393]). Sertoli cells play a key role in spermatogenesis ([@bibr59-1559325815592393]), and Leydig cells are the main source of androgen production ([@bibr3-1559325815592393]). Both types of cells can be readily affected by toxicants and chemical drugs ([@bibr49-1559325815592393]). This study was therefore undertaken to further examine the effects of artesunate on the oxidative parameters of the testis in adult male Swiss albino mice.

Recent studies suggest that artesunate could cause some histometrical changes in the rat testes by the sloughing of the germinal epithelium from the basement membrane and reduction in the population of the germ cells. These changes were apparently dose dependent ([@bibr26-1559325815592393]; [@bibr23-1559325815592393]).

Further, certain reports have shown that long-term administration of artesunate could induce reversible infertility in rats, which may act via distortion of blood--testis barrier formed by Sertoli cells ([@bibr47-1559325815592393]).

Histological studies carried out in our laboratory also revealed that artesunate caused significant alterations in testes of Swiss albino mice in a dose-dependent manner. The histological findings after hematoxylin and eosin staining indicated that the treated section of the testis showed some varying degree of cell clustering, cellular hypertrophy, and intercellular vacuolations, specifically in the germinal cell layer, resulting in a decline in sperm production ([@bibr53-1559325815592393]).

The global use of this antimalarial drug thus made its detailed investigation on male fertility imperative. Thus, there is a need to determine whether these observations may be applicable to humans, and in this regard, one can suggest that artesunate at normal dose could be a potential male antiferftility agent. We therefore recommend that further studies be carried out in humans to corroborate these findings and that self-medication involving artesunate should be discouraged.

Curcumin, an active component of turmeric (*Curcuma longa*), exhibits antioxidant property. It is a yellow-colored phenolic pigment obtained from the rhizome of turmeric (family Zingiberaceae). Curcumin is considered to be an effective antioxidant against oxidative tissue damage. It has been considered to be mediated via its beneficial effects on the antioxidant defense system, the scavenging of free radicals and/or via preventing lipid peroxidation (LPO; [@bibr30-1559325815592393]). Recent study revealed that antioxidant supplements such as curcumin can inhibit the harmful effects induced by nicotine on the hormones and quality and quantity of reproductive indices ([@bibr24-1559325815592393]). It can significantly inhibit the generation of reactive oxygen species (ROS) both in vitro and in vivo. ([@bibr27-1559325815592393]). Administration of curcumin to cadmium-treated rats prevents the cadmium-induced spermatogenic damage, decreased sperm count, reduced testosterone level, and generation of free radicals by inducing antioxidant defense mechanism ([@bibr58-1559325815592393]). Curcumin was shown to be a potent scavenger of a variety of reactive oxygen species including hydroxyl radicals, nitrogen dioxide radicals, and superoxide radicals ([@bibr51-1559325815592393]; [@bibr17-1559325815592393]). Curcumin has also been shown to alleviate various forms of male reproductive disorders in experimental animals, thereby enhancing fertility ([@bibr22-1559325815592393]; [@bibr41-1559325815592393]; [@bibr32-1559325815592393]). Additionally, as curcumin is used as a spice in human diet and is easily obtained in many shops, it is almost orally given by human and is used as an antioxidative agent. Therefore, in the present study, curcumin was selected as an antidote against artesunate-induced oxidative damage in testis of adult male Swiss albino mice.

Materials and Methods {#section2-1559325815592393}
=====================

Animals {#section3-1559325815592393}
-------

Healthy adult male albino mice, *Mus musculus* of Swiss strain weighing between 30 and 35 gm, were obtained from Cadila Pharaceuticals, Dholka, Gujarat, India. All the animals were acclimatized 7 days prior to the commencement of treatment and were maintained under controlled condition with 12-hour light and 12-hour dark cycles at temperature of 26°C ± 2°C and relative humidity of 30% to 70%. They were divided into 7 groups (A, B, C, D, E, and F) of 5 mice each. Group B mice were given 150 mg/kg body weight (bwt) of artesunate daily for 45 days, group C mice were given 300 mg/kg bwt of artesunate daily for 45 days, and group D mice were given 80 mg/kg bwt of curcumin for 45 days. Groups E and F mice were given 150 mg/kg bwt of artesunate + 80 mg/kg bwt of curcumin daily for 45 days and 300 mg/kg bwt of artesunate + 80 mg/kg bwt of curcumin daily for 45 days, respectively. Group A served as the control and were given only distilled water. The animals were fed on a commercial pellet supplied by Amrut mice feed (Pranav Agro Industries, Vadodara, Gujarat, India) and water ad libitum. Experiments were conducted in accordance with the guidelines set by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), India, and experimental protocols were approved by the institutional animals' ethics committee (167/1999/CPCSEA).

Experimental Design {#section4-1559325815592393}
-------------------

Artesunate was prepared in double-distilled water and orally given to mice via feeding canula with a hypodermic syringe.

Rationale for Selection of Doses {#section5-1559325815592393}
--------------------------------

In the present study, the dose of 150 mg/kg bwt (low dose) and 300 mg/kg bwt (high dose) were selected based on literature report of [@bibr4-1559325815592393]. All the doses for artesunate were derived from its equivalent to the therapeutic dose of artesunate for the treatment of uncomplicated malaria ([@bibr4-1559325815592393]). The dose for amelioration by curcumin (80 mg/kg bwt) was selected based on earlier reports by [@bibr22-1559325815592393], [@bibr41-1559325815592393], and [@bibr32-1559325815592393].

Experimental Protocol {#section6-1559325815592393}
---------------------

![](10.1177_1559325815592393-table4)

  Group   Group Name             Dosage                                                   Duration
  ------- ---------------------- -------------------------------------------------------- ----------
  A       Control                --                                                       45 days
  B       Low dose treated       150 mg/kg bwt of artesunate                              45 days
  C       High dose treated      300 mg/kg bwt of artesunate                              45 days
  D       Curcumin               80 mg/kg bwt of curcumin                                 45 days
  E       Low dose + curcumin    150 mg/kg bwt of artesunate + 80 mg/kg bwt of curcumin   45 days
  F       High dose + curcumin   300 mg/kg bwt of artesunate + 80 mg/kg bwt of curcumin   45 days

Vehicle: distilled water. Number of animals in each group (n) = 6.

Artesunate was administered per the experimental protocol. At the end of each treatment, animals were euthanized, and testis was carefully dissected out and weighed. Tissue was then processed for biochemical evaluation.

Hypothesis {#section7-1559325815592393}
==========

1.  **Null hypothesis:** Curcumin shows no ameliorative effects on artesunate-induced subchronic toxicity in testis of Swiss albino male mice.

2.  **Alternative hypothesis:** Curcumin shows ameliorative effects on artesunate-induced subchronic toxicity in testis of Swiss albino male mice.

Lipid Peroxidation Thiobarbutiric Acid Reactive Species {#section8-1559325815592393}
-------------------------------------------------------

The thiobarbutiric acid reactive species (TBARS) levels in testis of control and all treated animals were determined by the method of [@bibr45-1559325815592393]. The method is based on the formation of a red chromophore that absorbs at 532 nm following the reaction of thiobarbituric acid with MDA and other breakdown products of peroxidized lipids collectively called as TBARS.

Superoxide Dismutase {#section9-1559325815592393}
--------------------

The activity of superoxide dismutase (SOD) in testis of control and all treated animals was assayed by the modified spectrophotometric method of [@bibr28-1559325815592393]. In this method, the formazan formed at the end of the reaction indicates the presence of the enzyme. One unit of enzyme activity is defined as the enzyme concentration required to inhibit 50% of the optical density of chromogen formed in 1 minute at 560 nm under the assay condition.

Glutathione {#section10-1559325815592393}
-----------

The concentration of glutathione (GSH) in testis of control and all treated groups of mice was assayed by the method of [@bibr14-1559325815592393]. Glutathione present in the tissue oxidizes 5,5′-dithiobis-(2-nitrobenzoic acid) to form yellow-colored complex that can be read at 412 nm. The absorbance is proportional to the amount of GSH.

Glutathione Peroxidase {#section11-1559325815592393}
----------------------

Activity of glutathione peroxidase (G-Px) was estimated in testis of control and treated animals by the method of [@bibr57-1559325815592393]. Glutathione peroxidase acts on hydrogen peroxide (H~2~O~2~) and splits it into 2 water molecules. While doing so it consumes 2 hydrogen atoms from 2 molecules of GSH. As a by-product, 1 molecule of reduced glutathione (GS-SG) is obtained. Thus, the amount of GSH consumed per 10 minutes is related to activity of G-Px.

Glutathione Reductase {#section12-1559325815592393}
---------------------

The estimation of glutathione reductase (G-Rx) was done by the method of [@bibr8-1559325815592393]. Glutathione reductase can be measured by measuring the rate of nicotinamide adenine dinucleotide phosphate (NADPH) oxidation. The oxidation of NADPH to NADP^+^ is accompanied by a decrease in absorbance at 340 nm. Since G-Rx is present at rate-limiting concentrations, the rate of decrease is directly proportional to the G-Rx activity in the sample.

Glutathione-S-Transferase {#section13-1559325815592393}
-------------------------

Glutathione-S-transferase (GST) activity was measured in testis of control and treated group animals by modified method of [@bibr19-1559325815592393]. Glutathione-S-transferase catalyze the conjugation of GS-SG---via a sulfhydryl group---to electrophilic centers on a wide variety of substrates. Hence, the quantification of GSH--CDNB (1-Chloro-2,4-dinitrobenzene) conjugate formed by reaction of CDNB and GSH in presence of enzyme source may be used to measure the activity of GST.

Statistical Analysis {#section14-1559325815592393}
--------------------

All the data are presented as mean ± standard error. Statistical analysis was performed using the trial version of SPSS software package version 16.0. Comparison between the groups was made by 1-way analysis of variance (ANOVA) taking significance at *P* \< .05 followed by Student *t* test taking significance at \*\*\**P* \< .001, \*\**P* \< .005, and \**P* \< .01. Tukey honestly significance difference post hoc test was used for comparison among different treatment groups (*P* \< .05).

Results {#section15-1559325815592393}
=======

Biochemical Analysis {#section16-1559325815592393}
--------------------

Oral administration of low dose of artesunate for 45 days produced a significant increase (*P* \< .005) in LPO in testis (group B) when compared to the control group ([Table 1](#table1-1559325815592393){ref-type="table"}). At higher dose, artesunate exhibited significant increase (*P* \< .001) in LPO in testis of 45-day treated group (group C). On the other hand, supplementation of curcumin (80 mg/kg bwt) did not show significant LPO after 45 days (group D). Further, curcumin when supplemented along with artesunate low-dose and high-dose treatment showed nonsignificant decrease in LPO after 45 days of treatment (groups E and F; [Table 1](#table1-1559325815592393){ref-type="table"}, [Figure 1](#fig1-1559325815592393){ref-type="fig"}).

![Alteration in lipid peroxidation (LPO) thiobarbutiric acid reactive species (TBARS) content in testis of control and treated animals.](10.1177_1559325815592393-fig1){#fig1-1559325815592393}

###### 

Alteration in LPO (TBARS) and SOD Content in Testis of Control and Treated Animals.

![](10.1177_1559325815592393-table1)

  Groups                                                     LPO (nanomoles of MDA/mg tw/ 60 min)   SOD (units of SOD/mg protein)                         
  ---------------------------------------------------------- -------------------------------------- ------------------------------- --------- ----------- -----------
  Control (A)                                                62.5 ± 1.62                            0.35 ± 0.02                                           
  Artesunate (150 mg/kg bwt) (B)                             73.3 ± 2.85^b^                         0.28 ± 0.03^b^                                        
  Artesunate (300 mg/kg bwt) (C)                             76.6 ± 2.38^c^                         0.25 ± 0.03^c^                                        
  Curcumin (80 mg/kg bwt) (D)                                61.1 ± 2.50 NS                         0.37 ± 0.01 NS                                        
  Artesunate (150 mg/kg bwt) + Curcumin (80 mg/kg bwt) (E)   62.9 ± 3.10 NS                         0.33 ± 0.03 NS                                        
  Artesunate (300 mg/kg bwt) + Curcumin (80 mg/kg bwt) (F)   67.1 ± 2.47 NS                         0.30 ± 0.02 NS                                        
  Two-way ANOVA                                                                                                                                           
  Source of Variation                                        SS                                     *df*                            MS        *F* Value   *P* Value
  Between the groups (dosage)                                0.2129                                 3                               0.07097   6.041       .0005
  Within the groups (duration)                               4.887                                  416                             0.01175               

Abbreviations: ANOVA, analysis of variance; bwt, body weight; LPO-TBARS, lipid peroxidation thiobarbutiric acid reactive species; MDA, malonyldialdehyde; SE, standard error; SOD, superoxide dismutase; NS, nonsignificant analysis of variance at *P* \< .05 significance level.

^a^Values are mean ± SE.

^b^ *P* \< .005.

^c^ *P* \< .001.

Administration of artesunate at high dose (300 mg/kg bwt) for 45 days exhibited significantly decreased (*P* \< .001) SOD activity in testis. Similarly, low dose of artesunate at 45 days showed significant reduction (*P* \< .005) in SOD activity as compared with the control group values ([Table 2](#table2-1559325815592393){ref-type="table"}). Supplementation of curcumin along with low or high dose of artesunate brought about a recovery from the decrease in SOD activity after 45 days in the treated groups ([Table 1](#table1-1559325815592393){ref-type="table"}, [Figure 2](#fig2-1559325815592393){ref-type="fig"}).

###### 

Alteration in Oxidative Parameters GSH and GST Levels in Testis of Control and Treated Animals.^a^

![](10.1177_1559325815592393-table2)

  Groups                                                     GSH (µg/100 mg tissue wt)   GST (units/mg protein)                       
  ---------------------------------------------------------- --------------------------- ------------------------ ------- ----------- -----------
  Control (A)                                                37.11 ± 0.63                0.297 ± 0.03                                 
  Artesunate (150 mg/kg bwt) (B)                             27.20 ± 0.32^b^             0.317 ± 0.05^b^                              
  Artesunate (300 mg/kg bwt) (C)                             24.68 ± 0.63^c^             0.360 ± 0.07^c^                              
  Curcumin (80 mg/kg bwt) (D)                                42.50 ± 0.30 NS             0.280 ± 0.04 NS                              
  Artesunate (150 mg/kg bwt) + curcumin (80 mg/kg bwt) (E)   31.91 ± 0.50 NS             0.288 ± 0.01 NS                              
  Artesunate (300 mg/kg bwt) + curcumin (80 mg/kg bwt) (F)   28.62 ± 0.25 NS             0.288 ± 0.03 NS                              
  Two-way ANOVA Analysis                                                                                                              
  Source of Variation                                        SS                          *df*                     MS      *F* Value   *P* Value
  Between the groups (dosage)                                961.5                       3                        320.5   15.35       .0001
  Within the groups (duration)                               8687                        416                      20.88               

Abbreviations: ANOVA, analysis of variance; bwt, body weight; GSH, glutathione; GST, glutathione S transferase; NS, nonsignificant analysis of variance at *P* \< .05 significance level; SE, standard deviation.

^a^Values are mean ± SE.

^b^ *P* \< .005.

^c^ *P* \< .001.

![Alteration in superoxide dismutase (SOD) content in testis of control and treated animals.](10.1177_1559325815592393-fig2){#fig2-1559325815592393}

Similarly, the activity levels of GSH, G-Px, and G-Rx showed marked decline (*P* \< .005) after administration of low-dose artesunate for 45 days. Further, highly significant decrease was noted with administration of high-dose artesunate (*P* \< .001) in GSH, G-Px, and G-Rx after 45 days of treatment. Curcumin administered along with the artesunate low dose and high dose manifested an ameliorative effect, with recovery in activities of GSH, G-Px, and G-Rx in the testis after 45 days of treatment ([Tables 2](#table2-1559325815592393){ref-type="table"} and [3](#table3-1559325815592393){ref-type="table"}).

###### 

Alteration in Oxidative Parameters G-Px and G-Rx Levels in Testis of Control and Treated Animals.^a^

![](10.1177_1559325815592393-table3)

  Groups                                                     G-Px (GSH Consumed/mg Protein)   G-Rx (Moles NADPH Oxidized/min/mg Protein)                       
  ---------------------------------------------------------- -------------------------------- -------------------------------------------- ------- ----------- -----------
  Control (A)                                                11.98 ± 0.43                     0.93 ± 0.14                                                      
  Artesunate (150 mg/kg bwt) (B)                             8.72 ± 0.43^b^                   0.69 ± 0.03^b^                                                   
  Artesunate (300 mg/kg bwt) (C)                             7.90 ± 0.26^c^                   0.66 ± 0.04^c^                                                   
  Curcumin (80 mg/kg bwt) (D)                                14.06 ± 0.27 NS                  1.17 ± 0.14 NS                                                   
  Artesunate (150 mg/kg bwt) + curcumin (80 mg/kg bwt) (E)   9.37 ± 0.27 NS                   0.74 ± 0.02 NS                                                   
  Artesunate (300 mg/kg bwt) + curcumin (80 mg/kg bwt) (F)   9.42 ± 0.25 NS                   0.71 ± 0.02 NS                                                   
  Two-way ANOVA Analysis                                                                                                                                       
  Source of Variation                                        SS                               *df*                                         MS      *F* Value   *P* Value
  Between the groups (dosage)                                90.64                            3                                            30.21   11.08       .0001
  Within the groups (duration)                               1134                             416                                          2.726               

Abbreviations: ANOVA, analysis of variance; bwt, body weight; G-Px, glutathione peroxidase; G-Rx, glutathione reductase; GSH, glutathione; GST, glutathione S transferase; NS, nonsignificant analysis of variance at *P* \< .05 significance level; SE, standard deviation.

^a^Values are mean ± SE.

^b^ *P* \< .005.

^c^ *P* \< .001.

Contrary to this, the GST levels recorded significant increase (*P* \< .005) with low dose of artesunate at 45-day interval. The higher dosage also showed similar increase (*P* \< .001) after 45 days ([Table 2](#table2-1559325815592393){ref-type="table"}). Amelioration with curcumin revealed nonsignificant decrease in GST levels.

Based on the above-observed results, the null hypothesis has been rejected and the alternative hypothesis has been accepted, which suggests that curcumin shows ameliorative effects on artesunate-induced toxicity.

Discussion {#section17-1559325815592393}
==========

Despite the efforts to control malarial infection, it still prevails and perpetuates to pose great challenge to those living in endemic areas. Several factors have been reported to be responsible, including development of drug resistance to the potent and affordable drugs by the parasite ([@bibr46-1559325815592393]).

To combat these, use of artesunate as an alternative drug has been widely accepted. Artesunate exerts its antimalarial activity by the generation of reactive oxygen species (ROS) from its endoperoxide bond ([@bibr36-1559325815592393]) by iron (II)-heme produced during hemoglobin degradation, resulting in the generation of ROS ([@bibr25-1559325815592393]; [@bibr55-1559325815592393]) and leading to LPO ([@bibr56-1559325815592393]). The accumulation of lipid peroxides is toxic to the membrane structure, leading to a change in permeability and disintegration of cellular organelles ([@bibr39-1559325815592393]). In several situations, the rate of generation of ROS exceeds their removal, resulting in oxidative stress ([@bibr16-1559325815592393]). Similarly, studies of artemisinins on embryonic stem cells in mice have shown that these compounds raised intracellular levels of ROS ([@bibr62-1559325815592393]).

Oxidative stress also has long-term impact on male germ cell differentiation. It has been reported that oxidative stress inhibits spermatogenesis, decreases SOD activity, and induces DNA damage as well as apoptosis ([@bibr9-1559325815592393]). Under normal circumstances, the antioxidant enzymes of the cell get activated and effectively scavenge the free radicals restoring the normal cell environment. However, artesunate is known to inhibit protein synthesis in most mammalian systems by exposing the heptocyte to unprotectable oxidative injury, thus accounting for the degree of oxidative damage done by the accumulated artesunate and its metabolites ([@bibr63-1559325815592393]). Therefore, the significant decrease in GSH and SOD observed following artesunate treatment could result from enhanced utilization without augmented production. Artesunate has been reported to be a substrate of the GST detoxification system ([@bibr12-1559325815592393]). Most antimalarial agents had been shown to be toxic to male gonadal functions ([@bibr48-1559325815592393]; [@bibr52-1559325815592393]). Furthermore, various studies on the effects of artemisinins in male reproductive dysfunction had been centered on single artemisinin agents, using mice and albino rats ([@bibr52-1559325815592393]; [@bibr42-1559325815592393]).

Results of the present study revealed that treatment with antimalarial drug artesunate at low dose (150 mg/kg bwt) as well as high dose (300 mg/kg bwt) caused a significant depletion in the activities of various antioxidant enzymes such as SOD, GSH, G-Px, and G-Rx in testis tissue of the experimental male mice. Enhanced levels of LPO and GST were also observed in artesunate-treated mice. Moreover, the analysis of data using 2-way ANOVA at the *P* \< .005 level revealed that there was a statistically significant difference between the groups (based on dose), suggesting a dose-dependent toxic effect on administration of artesunate.

Superoxide radicals are one of the most important reactive oxygen free radicals constantly produced in the living cells ([@bibr40-1559325815592393]). Superoxide dismutase has antitoxic effect against the superoxide anion. Thus, the primary defense mechanism against superoxide anion is due to SOD activity and prevents further generation of free radicals ([@bibr13-1559325815592393]). In this context, the results of the present study showed that the SOD activity in the artesunate-treated mice decreased significantly due to oxidative stress in the testis.

The decreased SOD activity in turn could be responsible for increased LPO as well as decreased GSH level. The GSH/GST system is a critical factor in protection of cells and organs against toxicity. The thiol-containing metabolites reacts with GSH which are then converted into less harmful and more water-soluble molecules, and the reaction is catalyzed by enzyme GST. Artesunate treatment at both low and high dose brought about a significant reduction in GSH activity of testis of treated mice which clearly indicates the toxic effect of this antimalarial drug on body's defense mechanism.

There are several isoforms of G-Px in testis that use GSH as a source of electrons to reduce H~2~O~2~ to water. The phospholipid hydroperoxide G-Px is one of the most important G-Px isoforms in a testicular tissue and is highly expressed in both spermatogenic and Leydig cells ([@bibr5-1559325815592393]). In accordance with this report, the result of present study depicts the observed decline in G-Px levels.

Glutathione reductase is concerned with the maintenance of cellular level of GSH by affecting fast reduction in oxidized GSH to reduced form ([@bibr33-1559325815592393]). A decrease in the activity of G-Rx would further decrease the concentration of ascorbic acid. Our present finding showed decrease in activity of G-Rx which corroborates with that of earlier findings ([@bibr10-1559325815592393]).

Results of our investigation revealed a significant increase in the LPO in testis of mice treated with low- and high-dose artesunate. This suggests an increased peroxidation of lipids with concomitant loss of cellular functions in the body by artesunate treatment. Similar effects have been shown with fluoride toxicity in testis ([@bibr54-1559325815592393]).

Glutathione-S-transferase is a phase II detoxification antioxidant enzyme playing a key role in cellular detoxification by catalyzing the reaction of GSH with the toxicant to form an S-substituted GSH ([@bibr60-1559325815592393]). In the present study, the increase in the GST activity along with LPO suggests that GST is unable to utilize GSH and protect the tissue against the artesunate-induced toxicity.

Curcumin as an antioxidant may be an important component of an effective artesunate intoxication treatment. [@bibr15-1559325815592393] indicated that curcumin protected against testicular oxidative damage in rats induced by di-n-butylphthalate. Furthermore, [@bibr37-1559325815592393] have reported that curcumin ameliorated aflatoxin-induced LPO in liver, kidney, and testis of mice. Because of its safety record and multiple mechanisms of action, curcumin is useful as a valuable protective agent to ameliorate spermatogenesis dysfunction and cell loss ([@bibr32-1559325815592393]). The restoration of the concentration of testicular protein following the administration of the aqueous curcumin could enhance sperm maturation, indicating the androgenic potential of the plant. The significant reductions in the testicular total agree with previous studies of [@bibr29-1559325815592393]. Oral combination with curcumin could effectively counteract artesunate-induced oxidative testicular dysfunction as represented through ameolerating all oxidative stress and improving antioxidant defense system and prevent all toxic effect of artesunate.

The present investigation was carried out to explore the reproductive and oxidative effects of artesunate and the possible ameliorative role of curcumin in testis. Curcumin with low-dose and high-dose treatment significantly improved the level of enzymatic (SOD, G-Px, G-Rx, and GST) and nonenzymatic (GSH and LPO) components of the defense system. Results from this study indicate that curcumin might have protective effect against artesunate-induced oxidative stress in mice.

Conclusion {#section18-1559325815592393}
==========

Oral administration of curcumin could effectively stabilize artesunate-induced testicular dysfunction as represented through reduction in oxidative stress, improving antioxidant defense system and counteracting the toxic effects of artesunate. Thus, it was observed that artesunate caused a dose-dependent toxic effect in testis function in adult mice which has statistical confirmation from the 2-way ANOVA results. However, at an effective dose of 80 mg/kg bwt, curcumin brought about significant ameliorative recovery in the testicular toxicity.
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